labetalol has been researched along with Complications, Pregnancy in 15 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, the efficacy and safety of oral nifedipine and intravenous labetalol for severe pre-eclampsia therapy were compared." | 9.22 | Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. ( Shi, DD; Wang, N; Yang, FZ; Zhou, L, 2016) |
| "Labetalol was well tolerated and no significant maternal toxicity was noted." | 6.67 | Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. ( Campbell, DM; Cruickshank, DJ; MacGillivray, I; Robertson, AA, 1992) |
| "Fetal tachycardia was present as well." | 5.30 | Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. ( Bergmann, M; Bowman, ML; Smith, JF, 1998) |
| "In the present study, the efficacy and safety of oral nifedipine and intravenous labetalol for severe pre-eclampsia therapy were compared." | 5.22 | Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. ( Shi, DD; Wang, N; Yang, FZ; Zhou, L, 2016) |
| " Carboprost was used less frequently in patients with asthma compared with patients with no asthma (11." | 3.88 | Use of Antihypertensive Medications and Uterotonics During Delivery Hospitalizations in Women With Asthma. ( Ananth, CV; Booker, WA; Cleary, KL; DʼAlton, ME; Friedman, AM; Huang, Y; Siddiq, Z; Wright, JD, 2018) |
| " In response to moderate hypertension the patient received intravenous labetalol hydrochloride 20 mg." | 3.73 | Inadvertent intrathecal injection of labetalol in a patient undergoing post-partum tubal ligation. ( Balestrieri, PJ; Blank, RS; Grubb, CT; Hamza, MS; Ting, PH, 2005) |
| "Labetalol was well tolerated and no significant maternal toxicity was noted." | 2.67 | Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. ( Campbell, DM; Cruickshank, DJ; MacGillivray, I; Robertson, AA, 1992) |
| "Fetal tachycardia was present as well." | 1.30 | Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. ( Bergmann, M; Bowman, ML; Smith, JF, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Booker, WA | 1 |
| Siddiq, Z | 1 |
| Huang, Y | 1 |
| Ananth, CV | 1 |
| Wright, JD | 1 |
| Cleary, KL | 1 |
| DʼAlton, ME | 1 |
| Friedman, AM | 1 |
| Patel, V | 1 |
| Ramachandran, B | 1 |
| Omar, I | 1 |
| Shi, DD | 1 |
| Yang, FZ | 1 |
| Zhou, L | 1 |
| Wang, N | 1 |
| Merino, JL | 1 |
| Espejo, B | 1 |
| Ferreiro, P | 1 |
| Bueno, B | 1 |
| Paraíso, V | 1 |
| Balestrieri, PJ | 1 |
| Hamza, MS | 1 |
| Ting, PH | 1 |
| Blank, RS | 1 |
| Grubb, CT | 1 |
| Hatfield, T | 1 |
| Steiger, R | 1 |
| Wing, DA | 1 |
| de Vries, TW | 1 |
| van der Veer, E | 1 |
| Heijmans, HS | 1 |
| Tin, LN | 1 |
| Mulard, C | 1 |
| Talon, A | 1 |
| Garnier, JM | 1 |
| Lambert, A | 1 |
| Stroch-Marcy, A | 1 |
| Kamara, S | 1 |
| Chu, YL | 1 |
| Lin, SY | 1 |
| Lee, PC | 1 |
| Wang, YP | 1 |
| Lee, LH | 1 |
| Liu, CC | 1 |
| Bowman, ML | 1 |
| Bergmann, M | 1 |
| Smith, JF | 1 |
| Boulton, DW | 1 |
| Dakers, JM | 1 |
| Fawcett, JP | 1 |
| Fiddes, TM | 1 |
| Midgley, DY | 1 |
| Khalaf, Y | 1 |
| Braude, PR | 1 |
| Nelson-Piercy, C | 1 |
| Magee, LA | 1 |
| Bull, SB | 1 |
| Koren, G | 1 |
| Logan, A | 1 |
| Cruickshank, DJ | 1 |
| Robertson, AA | 1 |
| Campbell, DM | 1 |
| MacGillivray, I | 1 |
2 reviews available for labetalol and Complications, Pregnancy
| Article | Year |
|---|---|
Goodpasture's disease in pregnancy: case report and review of the literature.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antihypertensive Agents; Female; Humans; Hypertens | 2007 |
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Cohort Studies; Databases as Topic; Diabetes, Gestational; Femal | 2001 |
2 trials available for labetalol and Complications, Pregnancy
| Article | Year |
|---|---|
Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; D | 2016 |
Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study.
Topics: Adult; Female; Humans; Hypertension; Labetalol; Pregnancy; Pregnancy Complications; Pregnancy Compli | 1992 |
11 other studies available for labetalol and Complications, Pregnancy
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Use of Antihypertensive Medications and Uterotonics During Delivery Hospitalizations in Women With Asthma.
Topics: Adult; Antihypertensive Agents; Asthma; Carboprost; Contraindications, Drug; Databases, Factual; Del | 2018 |
Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Aspirin; Diagnosis, Differential; Factor V; Female; Hea | 2019 |
[Pregnancy and advanced chronic kidney disease].
Topics: Ductus Arteriosus, Patent; Epilepsy; Female; Fetal Growth Retardation; Humans; Hyaline Membrane Dise | 2010 |
Inadvertent intrathecal injection of labetalol in a patient undergoing post-partum tubal ligation.
Topics: Adult; Analgesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Antihypertensive Agents; Bupi | 2005 |
Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
Topics: Acenocoumarol; Bone and Bones; Developmental Disabilities; Drug Combinations; Female; Fetal Diseases | 1993 |
[Subcapsular liver hematoma, a HELLP syndrome complication].
Topics: Adult; Cesarean Section; Combined Modality Therapy; Female; HELLP Syndrome; Hematoma; Humans; Labeta | 1994 |
The role of labetalol and propofol in the management of HELLP syndrome--a case report.
Topics: Adult; Anesthetics, Intravenous; Antihypertensive Agents; Female; HELLP Syndrome; Humans; Labetalol; | 1996 |
Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis.
Topics: Adolescent; Female; Fetal Diseases; Heart Rate, Fetal; Humans; Hypertension; Infant, Newborn; Infant | 1998 |
Transplacental distribution of labetalol stereoisomers at delivery.
Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Labor, Obstetric; Maternal- | 1999 |
Recurrent cholestasis following ovarian hyperstimulation syndrome: case report.
Topics: Adult; Antihypertensive Agents; Cesarean Section; Cholestasis; Female; Fertilization in Vitro; Gesta | 1999 |